Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hepatitis C

  Free Subscription


1 Clin Res Hepatol Gastroenterol
3 J Viral Hepat
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Clin Res Hepatol Gastroenterol

  1. EL-KASSAS M, Elbehiry S, Rezk E, Omran D, et al
    Discontinuing Directly Acting Antivirals During Hepatitis C Treatment: Highlighting an Infrequent but Hostile Event.
    Clin Res Hepatol Gastroenterol. 2022 Oct 22:102042.

    J Viral Hepat

  2. BITTENCOURT PL, Iasi MDSF, Viana MV, Crespo DM, et al
    Poor linkage to care may compromise the brazilian plan for hepatitis c elimination.
    J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13762.
    PubMed         Abstract available

  3. CASEY JL, Dore GJ, Grebely J, Matthews GV, et al
    Hepatitis C Virus-Specific Immune Responses Following Direct Acting Antivirals Administered During Recent Hepatitis C Virus Infection.
    J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13761.
    PubMed         Abstract available

  4. CHADHA N, Turner A, Sterling RK
    Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR.
    J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13763.
    PubMed         Abstract available

    PLoS One

  5. YAMATAKA K, Chu PS, Koda Y, Taniki N, et al
    Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.
    PLoS One. 2022;17:e0276925.
    PubMed         Abstract available

  6. CHIA CT, Bender AT, Lillis L, Sullivan BP, et al
    Rapid detection of hepatitis C virus using recombinase polymerase amplification.
    PLoS One. 2022;17:e0276582.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.